Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand

被引:17
|
作者
Boon-yasidhi, Vitharon [1 ]
Chokephaibulkit, Kulkanya [1 ]
McConnell, Michelle S. [2 ]
Vanprapar, Nirun [1 ]
Leowsrisook, Pimsiri [3 ]
Prasitsurbsai, Wasana [1 ]
Durier, Yuitiang [1 ]
Klumthanom, Kanyarat [4 ]
Patel, Alpa [2 ]
Sukwicha, Wichuda [4 ]
Naiwatanakul, Thananda [4 ]
Chotpitayasunond, Tawee [3 ]
机构
[1] Mahidol Univ, Fac Med, Dept Pediat, Siriraj Hosp, Bangkok 10700, Thailand
[2] US Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Minist Publ Hlth, Dept Pediat, QSNICH, Bangkok, Thailand
[4] GAP, Thailand MOPH US CDC Collaborat TUC, Bangkok, Thailand
关键词
HIV; diagnosis; disclosure; model; children; HUMAN-IMMUNODEFICIENCY-VIRUS; ADOLESCENTS; HIV/AIDS;
D O I
10.1080/09540121.2012.749331
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
While disclosure of HIV status to perinatally HIV-infected children has become an increasingly important clinical issue, specific disclosure guidelines are lacking. We developed a pediatric HIV diagnosis disclosure model to support caretakers. All HIV-infected children greater than 7-years-old at two participating hospitals in Bangkok, Thailand, and their caretakers, were offered disclosure according to the 4-step protocol: (1) screening; (2) readiness assessment; (3) disclosure; and (4) follow-up. Disclosure occurred after agreement of both providers and caretakers. Among 438 children who were screened, 398 (89%) were eligible. Readiness assessment was completed for 353 (91%) of eligible children and 216 (61%) were determined ready. Disclosure was done for 186 children. The mean age at eligibility screening was 10.5 years (range: 6.8-15.8 years); the mean age at disclosure was 11.7 years (range: 7.6-17.7 years). The mean duration between eligibility screening and disclosure was 15.2 months. There were no significant negative behavioral or emotional outcomes reported in children following disclosure. This HIV diagnosis disclosure model was feasible to implement and had no negative outcomes. As the time for preparation process was over 1 year for most cases, the disclosure process can be initiated as early as age 7 to allow enough time for disclosure to be completed by the age of adolescence.
引用
收藏
页码:756 / 762
页数:7
相关论文
共 50 条
  • [1] Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand
    Oberdorfer, Peninnah
    Puthanakit, Thanyawee
    Louthrenoo, Orawan
    Charnsil, Chawanun
    Sirisanthana, Virat
    Sirisanthana, Thira
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (05) : 283 - 288
  • [2] Disclosure of HIV status to sexual partners among perinatally HIV-infected youth in Thailand
    Boon-yasidhi, Vitharon
    Torsakul, Sumonmal
    Durier, Yuitiang
    Sittanomai, Napat
    Kuntasorn, Jeeranan
    Chokephaibulkit, Kulkanya
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (04) : 361 - 367
  • [3] Factors associated with caretaker's readiness for disclosure of HIV diagnosis to HIV-infected children in Bangkok, Thailand
    Punpanich, W.
    Lolekha, R.
    Chokephaibulkit, K.
    Naiwatanakul, T.
    Leowsrisook, P.
    Boon-yasidhi, V.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (13) : 929 - 935
  • [4] Disclosure of the diagnosis of HIV/AIDS to children born of HIV-infected mothers
    Lee, CL
    Johann-Liang, R
    AIDS PATIENT CARE AND STDS, 1999, 13 (01) : 41 - 45
  • [5] Hearing sensitivity in perinatally HIV-infected children
    Peter Torre
    Alyssa Cook
    Hannah Martin
    Haley Elliott
    Gouwa Dawood
    Barbara Laughton
    BMC Infectious Diseases, 14 (Suppl 2)
  • [6] IgE and atopy in perinatally HIV-infected children
    Bowser, CS
    Kaye, J
    Charlot, C
    Joks, R
    Moallem, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S287 - S287
  • [7] Disclosure of HIV diagnosis to HIV-infected children in South Africa: Focus groups for intervention development
    Heeren, G. Anita
    Jemmott, John B., III
    Sidloyi, Lulama
    Ngwane, Zolani
    Tyler, Joanne C.
    VULNERABLE CHILDREN AND YOUTH STUDIES, 2012, 7 (01) : 47 - 54
  • [8] CNS affection in perinatally HIV-infected children
    Funk, M
    JosephSteiner, J
    HernaizDriever, P
    Mentzer, D
    GohlichRatmann, G
    Bollinger, M
    Kreuz, W
    Kornhuber, B
    Jacobi, G
    KLINISCHE PADIATRIE, 1996, 208 (05): : 299 - 303
  • [9] IgE and atopy in perinatally HIV-infected children
    Bowser, Corinna S.
    Kaye, Jean
    Joks, Rauno O.
    Charlot, Cascy-Arnoux
    Moallem, H. Jack
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2007, 18 (04) : 298 - 303
  • [10] NEURORADIOLOGICAL FINDINGS IN PERINATALLY HIV-INFECTED CHILDREN
    SPREER, J
    ENENKELSTOODT, S
    FUNK, M
    FIEDLER, A
    DESIMONE, A
    HACKER, H
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1994, 161 (02): : 106 - 112